Asbestos at Bethlehem Steel Shipyards

Imagine spending a full career in the belly of a ship, insulating pipes and boilers with materials that your employer knew were dangerous. For hundreds of thousands of workers at Bethlehem Steel's shipyards, that scenario wasn't hypothetical. It was the daily reality of mid-20th century shipbuilding, and it left a legacy of mesothelioma, asbestosis, and lung cancer that persists to this day. Bethlehem Steel Corporation, once the second-largest steel producer in the United States and a dominant force in American shipbuilding, operated major shipyard facilities from the 1890s through the late 20th century. Workers at locations including Sparrows Point in Baltimore, the Fore River Shipyard in Quincy, Massachusetts, and the Union Iron Works in San Francisco were exposed to asbestos in virtually every area of ship construction.

According to the National Cancer Institute, asbestos is the leading cause of pleural mesothelioma, a rare and aggressive cancer of the lining surrounding the lungs. Shipyard environments were among the most asbestos-saturated workplaces in American industrial history. The U.S. Navy and private shipbuilders alike mandated the use of asbestos-containing materials in ships because of the mineral's resistance to heat, fire, and corrosion. Bethlehem Steel's shipyards, which produced destroyers, cruisers, and cargo vessels for the U.S. military, relied heavily on asbestos insulation from the 1930s onward.

The company's own internal documents, later surfaced during litigation, showed that Bethlehem Steel executives were aware of the health hazards associated with asbestos exposure as early as the 1940s. Despite this knowledge, adequate protective equipment was rarely provided to workers, and warnings were not issued. As a result, workers, their families (who could be exposed through fibers carried home on clothing), and nearby residents faced serious long-term health consequences. The scale of this exposure and the corporate awareness that preceded it made Bethlehem Steel a central figure in what the RAND Corporation has called the largest mass tort litigation in American history.

Workers who were exposed to asbestos at Bethlehem Steel shipyards often don't develop symptoms until decades after their exposure ended. This long latency period, typically 20 to 50 years according to the American Cancer Society, means that many former shipyard workers are only now receiving diagnoses of asbestos-related diseases. The diseases associated with shipyard asbestos exposure fall into several categories, each with its own symptom profile.

Mesothelioma is the most serious and most directly linked condition. Pleural mesothelioma, which affects the lining of the lungs, causes shortness of breath, chest pain, and persistent dry cough. Fluid accumulation around the lungs (pleural effusion) is common and can cause significant discomfort. Asbestosis, a chronic scarring of the lung tissue, produces progressive shortness of breath, a crackling sound when breathing, and in advanced cases, clubbing of the fingers. Lung cancer attributable to asbestos exposure presents similarly to smoking-related lung cancer, with chronic cough, coughing up blood, unexplained weight loss, and chest pain. According to the National Institute for Occupational Safety and Health (NIOSH), workers who both smoked and were exposed to asbestos face a risk of lung cancer up to 90 times greater than the general population.

• Pleural plaques: Thickened patches on the lung lining, often an early marker of past exposure
• Pleural effusion: Fluid buildup around the lungs, causing breathlessness
• Persistent cough and shortness of breath: Common to multiple asbestos-related conditions
• Unexplained weight loss and fatigue: Systemic symptoms often accompanying mesothelioma
• Chest tightness and pain: Particularly associated with pleural disease

Any former Bethlehem Steel shipyard worker experiencing these symptoms should inform their physician of their occupational history. Early detection remains one of the most important factors in treatment outcomes, even though no asbestos-related disease is currently curable.

Bethlehem Steel's shipyards were, by the standards of occupational health science, extraordinarily hazardous environments. Asbestos fibers were released into the air during virtually every phase of ship construction and repair. Insulators, pipefitters, boilermakers, electricians, carpenters, and even painters worked alongside one another in enclosed ship compartments where asbestos dust had nowhere to go. According to a 2003 study published in the American Journal of Industrial Medicine, shipyard workers had some of the highest rates of mesothelioma of any occupational group in the United States, a finding consistent with the fiber concentrations measured in shipyard environments during the mid-20th century.

The specific asbestos-containing products used at Bethlehem Steel shipyards included pipe insulation, boiler insulation, gaskets, packing materials, deck tiles, fireproofing compounds, and insulating cement. Manufacturers such as Johns-Manville, Owens Corning, and Unarco supplied many of these materials. Internal correspondence from Johns-Manville, revealed during litigation in the 1970s and 1980s, confirmed that manufacturers and large industrial clients including shipbuilders had shared knowledge of asbestos's health dangers well before warnings were ever issued to workers. Bethlehem Steel itself received warnings from the insurance industry as early as 1947 about the dangers of asbestos dust in enclosed spaces.

Three primary fiber types were used extensively in shipbuilding: chrysotile (white asbestos), amosite (brown asbestos), and crocidolite (blue asbestos). Amosite and crocidolite are considered the most carcinogenic. All three were present in Bethlehem Steel's facilities. According to the Agency for Toxic Substances and Disease Registry (ATSDR), there is no known safe level of asbestos exposure, and even brief exposures to high concentrations, such as those common in shipyard environments, can be sufficient to cause mesothelioma decades later.

Not every worker at a Bethlehem Steel shipyard faced identical risk. Exposure levels varied significantly based on job title, work location, and era. However, certain trades consistently show the highest rates of asbestos-related disease in occupational health literature.

Insulators, also called laggers, faced the greatest risk. Their primary job was to apply and remove asbestos insulation from pipes and machinery, activities that generated dense clouds of respirable fibers. A landmark study by Dr. Irving Selikoff and colleagues at the Mount Sinai School of Medicine, published in the Journal of the American Medical Association in 1964, documented dramatically elevated rates of asbestosis and lung cancer among insulation workers, many of whom had worked in shipyards. That study is widely credited with establishing the scientific foundation for modern asbestos regulation in the United States.

• Highest-risk trades: Insulators, pipefitters, boilermakers, shipfitters, and welders
• Moderate-risk trades: Electricians, machinists, carpenters, and painters
• Secondary exposure risk: Family members who laundered work clothing contaminated with asbestos fibers
• Duration of employment: Workers with 10 or more years in shipyard environments faced compounding risk
• Smoking history: Combined with asbestos exposure, cigarette smoking dramatically multiplies lung cancer risk

Workers employed at Bethlehem Steel during World War II, when production demands were at their peak and safety oversight was minimal, faced the highest cumulative exposures. The Sparrows Point facility in Baltimore, which at its height employed more than 35,000 workers, is particularly well-documented in both occupational health research and asbestos litigation records.

A former Bethlehem Steel shipyard worker who presents with respiratory symptoms today will typically undergo a diagnostic workup that begins with a detailed occupational history. Physicians trained in occupational medicine understand that a history of shipyard work, even 40 or 50 years ago, is a significant red flag for asbestos-related disease. According to the American Thoracic Society, the occupational history is the single most important diagnostic tool in identifying asbestos-related conditions.

Imaging studies are the next step. A chest X-ray can reveal pleural plaques, which are calcified patches on the lung lining that indicate past asbestos exposure. High-resolution computed tomography (CT) scans provide more detailed images and can detect early-stage asbestosis or pleural thickening that X-rays might miss. For suspected mesothelioma, CT scans of the chest and abdomen are standard, often followed by positron emission tomography (PET) scans to assess disease spread. According to the National Cancer Institute, a definitive mesothelioma diagnosis requires a tissue biopsy, typically obtained through thoracoscopy (video-assisted surgical sampling of the pleural lining) or CT-guided needle biopsy. Pathological analysis must distinguish mesothelioma from other cancers, particularly lung adenocarcinoma, which can present similarly. Immunohistochemical staining using markers such as calretinin and WT-1 helps confirm a mesothelioma diagnosis. Pulmonary function tests are used to assess the degree of lung impairment in cases of suspected asbestosis. A reduced forced vital capacity (FVC) combined with a normal or elevated ratio of FVC to forced expiratory volume (FEV1) is characteristic of the restrictive pattern seen in asbestosis.

Treatment for asbestos-related diseases diagnosed in former Bethlehem Steel workers follows the same clinical pathways used for any patient with these conditions, though a patient's age and overall health, both of which may be affected by decades of industrial work, can influence what options are available. There is currently no cure for mesothelioma or asbestosis, but multiple treatment modalities can extend life and improve quality of life.

For pleural mesothelioma, the standard first-line treatment since 2003 has been a combination of cisplatin and pemetrexed (Alimta), following the landmark EMPHACIS trial published in the Journal of Clinical Oncology. This regimen demonstrated a median survival benefit of approximately three months compared to cisplatin alone, with a median overall survival of 12.1 months in the combination group. In 2020, the U.S. Food and Drug Administration approved nivolumab plus ipilimumab (Opdivo plus Yervoy) as a first-line immunotherapy option for unresectable pleural mesothelioma, based on the CheckMate 743 trial, which showed a median overall survival of 18.1 months compared to 14.1 months with standard chemotherapy. For patients with early-stage disease and good performance status, surgery such as extrapleural pneumonectomy or pleurectomy/decortication may be considered, often combined with chemotherapy and radiation in a multimodal approach. For asbestosis, treatment is supportive rather than curative. Pulmonary rehabilitation, supplemental oxygen therapy, and management of complications such as pulmonary hypertension are the primary interventions. Patients with asbestosis should receive annual influenza vaccination and pneumococcal vaccination, as respiratory infections can be particularly dangerous with compromised lung function.

The prognosis for asbestos-related diseases diagnosed in former Bethlehem Steel workers depends heavily on which condition is present and how early it is detected. Mesothelioma carries the most serious prognosis. According to the American Cancer Society, the five-year survival rate for pleural mesothelioma remains below 12 percent across all stages, reflecting the disease's typical late-stage diagnosis and aggressive behavior. However, patients diagnosed at an early stage (Stage I or II) who are eligible for multimodal treatment have achieved median survival times of 20 months or more in specialized centers, and some long-term survivors have been documented in the medical literature.

Asbestosis is a progressive condition with no known way to halt its advancement. The rate of progression varies significantly between individuals. Some patients live for many years with stable, mild disease, while others experience rapid decline in lung function. The presence of asbestosis also increases the risk of developing lung cancer and mesothelioma, compounding the long-term prognosis. A 2017 review in the journal Respirology found that the mortality rate from asbestosis in the United States has remained stubbornly elevated despite decades of regulatory progress, reflecting the long latency of the disease and the large number of workers exposed before regulations took effect. For former Bethlehem Steel workers and their families, understanding the prognosis is deeply tied to understanding legal and financial options. Many patients with mesothelioma have successfully pursued compensation through asbestos trust funds established by bankrupt manufacturers and through direct litigation, which can help cover medical costs and provide for surviving family members.

A diagnosis of mesothelioma or asbestosis connected to Bethlehem Steel shipyard work carries weight that extends far beyond the medical. Many patients are in their 60s, 70s, or 80s, having spent their working lives in physically demanding jobs. The diagnosis often arrives as a profound injustice: you did your job, built ships that served your country, and are now facing a fatal illness that your employer could have prevented.

Support resources for former Bethlehem Steel workers and their families include the Mesothelioma Applied Research Foundation (MARF), which funds research and connects patients with clinical trials, and the Asbestos Disease Awareness Organization (ADAO), which provides advocacy and community support. Many major cancer centers, including Johns Hopkins (which is located near the Sparrows Point facility), MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center, have dedicated mesothelioma programs with multidisciplinary teams experienced in treating occupationally exposed patients. Legal consultation is a practical step that many families pursue alongside medical treatment. Because Bethlehem Steel declared bankruptcy in 2001, direct litigation against the company is no longer possible, but workers may be eligible for compensation through asbestos bankruptcy trust funds established by the manufacturers of asbestos-containing products used at Bethlehem Steel facilities. An experienced mesothelioma attorney can help identify which trusts apply to a specific work history. Financial assistance may also be available through the Social Security Administration's compassionate allowance program, which expedites disability claims for mesothelioma patients, and through Veterans Affairs benefits for workers who also served in the military.